Literature DB >> 19414001

Amygdaloid axons innervate melanin-concentrating hormone- and orexin-containing neurons in the mouse lateral hypothalamus.

Sawako Nakamura1, Toshiko Tsumori, Shigefumi Yokota, Tatsuro Oka, Yukihiko Yasui.   

Abstract

This study was performed to understand the anatomical substrates of amygdaloid modulation of feeding-related peptides-containing neurons in the lateral hypothalamic area (LHA). After biotinylated dextranamine (BDA) injection into the central amygdaloid nucleus (CeA) and immunostaining of melanin-concentrating hormone (MCH)- or orexin (ORX)-containing hypothalamic neurons in the mouse, the prominent overlap of the distribution field of the BDA-labeled fibers and that of the MCH-immunoreactive (ir) or ORX-ir neurons was found in the dorsolateral part of the LHA, and the labeled axon terminals made symmetrical synaptic contacts with somata and dendrites of the MCH-ir or ORX-ir neurons. It was further revealed that nearly all the BDA-labeled axon terminals in the dorsolateral part of LHA were immunoreactive for glutamic acid decarboxylase, an enzyme for conversion of glutamic acid to gamma-aminobutyric acid (GABA). The present data suggest that the CeA is involved in the regulation of feeding behavior by exerting its GABAergic inhibitory action upon the MCH- and ORX-containing LHA neurons.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19414001     DOI: 10.1016/j.brainres.2009.04.049

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  The brain orexin system and almorexant in fear-conditioned startle reactions in the rat.

Authors:  Michel A Steiner; Hugues Lecourt; Francois Jenck
Journal:  Psychopharmacology (Berl)       Date:  2012-05-17       Impact factor: 4.530

2.  Organization of connections between the amygdala, medial prefrontal cortex, and lateral hypothalamus: a single and double retrograde tracing study in rats.

Authors:  Christina J Reppucci; Gorica D Petrovich
Journal:  Brain Struct Funct       Date:  2015-07-14       Impact factor: 3.270

3.  Concentration-dependent activation of dopamine receptors differentially modulates GABA release onto orexin neurons.

Authors:  Victoria Linehan; Robert B Trask; Chantalle Briggs; Todd M Rowe; Michiru Hirasawa
Journal:  Eur J Neurosci       Date:  2015-06-26       Impact factor: 3.386

Review 4.  The Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic.

Authors:  Evan D Paul; Philip L Johnson; Anantha Shekhar; Christopher A Lowry
Journal:  Neurosci Biobehav Rev       Date:  2014-03-21       Impact factor: 8.989

5.  Central Amygdala Projections to Lateral Hypothalamus Mediate Avoidance Behavior in Rats.

Authors:  Marcus M Weera; Rosetta S Shackett; Hannah M Kramer; Jason W Middleton; Nicholas W Gilpin
Journal:  J Neurosci       Date:  2020-11-13       Impact factor: 6.167

6.  Stimulation of lateral hypothalamic glutamate and acetylcholine efflux by nicotine: implications for mechanisms of nicotine-induced activation of orexin neurons.

Authors:  Ravi K Pasumarthi; Jim Fadel
Journal:  J Neurochem       Date:  2010-03-04       Impact factor: 5.372

Review 7.  Stress exposure, food intake and emotional state.

Authors:  Yvonne M Ulrich-Lai; Stephanie Fulton; Mark Wilson; Gorica Petrovich; Linda Rinaman
Journal:  Stress       Date:  2015-08-13       Impact factor: 3.493

Review 8.  Forebrain networks and the control of feeding by environmental learned cues.

Authors:  Gorica D Petrovich
Journal:  Physiol Behav       Date:  2013-04-03

Review 9.  Cell type- and pathway-specific synaptic regulation of orexin neurocircuitry.

Authors:  Jing-Jing Liu; Vincent R Mirabella; Zhiping P Pang
Journal:  Brain Res       Date:  2018-10-05       Impact factor: 3.252

Review 10.  Orexin/hypocretin role in reward: implications for opioid and other addictions.

Authors:  Corey Baimel; Selena E Bartlett; Lih-Chu Chiou; Andrew J Lawrence; John W Muschamp; Omkar Patkar; Li-Wei Tung; Stephanie L Borgland
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.